TransMedics Group
$14.239876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.06 (-0.42%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell TMDX and other stocks, options, ETFs, and crypto commission-free!
About TMDX
TransMedics Group, Inc. Common Stock, also called TransMedics Group, is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. Read More It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA. The listed name for TMDX is TransMedics Group, Inc. Common Stock.
Employees
109
Headquarters
Andover, Massachusetts
Founded
1998
Market Cap
386.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
313.06K
High Today
$14.36
Low Today
$13.94
Open Price
$14.28
Volume
99.12K
52 Week High
$24.69
52 Week Low
$10.10
Collections
TMDX Earnings
-$4.86
-$3.24
-$1.62
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 4, After Hours